SGARZI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 159
EU - Europa 144
AS - Asia 50
SA - Sud America 6
AF - Africa 3
Totale 362
Nazione #
US - Stati Uniti d'America 158
IT - Italia 51
CN - Cina 36
FR - Francia 27
IE - Irlanda 19
DE - Germania 18
BG - Bulgaria 10
AE - Emirati Arabi Uniti 5
GB - Regno Unito 5
CZ - Repubblica Ceca 4
BR - Brasile 3
VN - Vietnam 3
FI - Finlandia 2
JP - Giappone 2
KE - Kenya 2
NL - Olanda 2
PE - Perù 2
RU - Federazione Russa 2
AT - Austria 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
IN - India 1
PK - Pakistan 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 362
Città #
Ashburn 25
Beijing 23
Dublin 19
Bologna 16
Santa Cruz 14
Seattle 11
Sofia 10
Woodbridge 8
Buffalo 7
Forlì 7
Los Angeles 7
Bremen 6
New York 6
Chicago 5
Fairfield 5
Houston 5
Paris 5
Mariano Comense 4
Boardman 3
Milan 3
Rimini 3
Southend 3
Brno 2
Dongguan 2
Falkenstein 2
Lucca 2
Munich 2
Nuremberg 2
Portland 2
Rome 2
Trujillo 2
Amsterdam 1
Andover 1
Ann Arbor 1
Atlanta 1
Auburn 1
Basking Ridge 1
Cambridge 1
Central 1
Cesena 1
Cheyenne 1
Columbus 1
Crugers 1
Curitiba 1
Des Moines 1
Dong Ket 1
Fleming Island 1
Frankfurt am Main 1
Galdakao 1
Helsinki 1
Herndon 1
Islamabad 1
Lappeenranta 1
Lincoln 1
Liverpool 1
Medicina 1
Milpitas 1
Montreal 1
Mountain View 1
Muizenberg 1
Navi Mumbai 1
New Orleans 1
Padova 1
Reston 1
San Francisco 1
San Jose 1
San Mauro Pascoli 1
Scranton 1
Taipei 1
Tokyo 1
Vienna 1
Totale 253
Nome #
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects, file e1dcb335-b3e9-7715-e053-1705fe0a6cc9 115
null, file e1dcb332-948e-7715-e053-1705fe0a6cc9 71
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file daf66676-7c72-4ae8-aad0-62753fad4fdb 36
The roadmap of colorectal cancer screening, file e1dcb338-0430-7715-e053-1705fe0a6cc9 35
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies, file e1dcb335-ba8f-7715-e053-1705fe0a6cc9 25
The roadmap of colorectal cancer screening, file e1dcb339-fec8-7715-e053-1705fe0a6cc9 18
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy, file 47f7078a-55a7-4d43-b181-852a8d166d99 17
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells, file e1dcb339-ce59-7715-e053-1705fe0a6cc9 14
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression, file aebe601e-ce31-4ae5-843d-d6ccb19efae0 12
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies, file 344c1542-5025-468c-9e7e-4e95af819a3d 10
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies, file 64f16e7d-52b5-4113-9b9b-46de93f002ff 7
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation, file 3cb30e67-dfed-42a6-b602-e39255abdfe9 6
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation, file 671c4992-d787-4fd4-8e1a-54278e2073fc 4
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer, file 04105a15-9cb3-4264-9f8b-06761ed18ce0 3
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells, file b168c98c-61d8-4576-8cc9-942c621f1e95 1
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization, file dabb68c4-e842-4c9f-92ef-9f8a92d8f721 1
Totale 375
Categoria #
all - tutte 1.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 1 0 0 0 0 1 1 0 3
2020/202148 0 6 0 4 0 4 5 7 9 4 6 3
2021/202259 3 0 1 7 7 1 2 3 2 1 24 8
2022/2023112 3 4 15 15 16 2 2 6 24 5 15 5
2023/2024150 5 3 2 28 2 34 6 18 23 29 0 0
Totale 375